WallStreetZenWallStreetZen

NASDAQ: DNLI
Denali Therapeutics Inc Stock Ownership - Who owns Denali Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Denali Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Steve E. KrognesDirector2024-04-0192,500$20.50
$1.90MSell
Vicki L. SatoDirector2024-03-151,666$20.10
$33.49kSell
Vicki L. SatoDirector2024-02-151,666$18.37
$30.60kSell
Carole HoChief Medical Officer2024-02-141,405$17.79
$24.99kSell
Alexander O. SchuthCOFO and Secretary2024-02-1420,128$17.66
$355.46kSell
Ryan J. WattsPresident and CEO2024-02-139,589$17.29
$165.79kSell
Carole HoChief Medical Officer2024-02-132,784$17.29
$48.14kSell
Alexander O. SchuthCOFO and Secretary2024-02-132,716$17.29
$46.96kSell
Steve E. KrognesDirector2024-02-132,750$17.29
$47.55kSell
Alexander O. SchuthCOFO and Secretary2024-02-0850,000$0.68
$34.00kBuy

1 of 5

DNLI insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when DNLI insiders and whales buy or sell their stock.

DNLI Shareholders

What type of owners hold Denali Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Robert Nelsen14.91%20,749,930$378.89MInsider
Baillie Gifford Co10.25%14,260,724$260.40MInstitution
Biogen Inc9.56%13,310,243$243.05MInsider
Blackrock Inc8.30%11,543,446$210.78MInstitution
Vanguard Group Inc7.79%10,834,483$197.84MInstitution
Arch Venture Fund Viii LP7.67%10,668,749$194.81MInsider
Douglas K. Bratton7.25%10,084,938$184.15MInsider
Fmr LLC7.03%9,779,988$178.58MInsider
Flagship Ventures Fund V LP6.41%8,918,749$162.86MInsider
Wellington Management Group LLP5.23%7,274,717$132.84MInstitution

1 of 3

DNLI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
DNLI56.52%43.48%Net SellingNet Selling
CGON0.00%16.44%Net BuyingNet Buying
VERA55.23%44.77%Net SellingNet Selling
RYTM87.97%12.03%Net SellingNet Selling
SMMT4.61%92.95%Net BuyingNet Buying
View Top Biotech Stocks

Denali Therapeutics Stock Ownership FAQ

Who owns Denali Therapeutics?

Denali Therapeutics (NASDAQ: DNLI) is owned by 79.56% institutional shareholders, 61.21% Denali Therapeutics insiders, and 0.00% retail investors. Robert Nelsen is the largest individual Denali Therapeutics shareholder, owning 20.75M shares representing 14.91% of the company. Robert Nelsen's Denali Therapeutics shares are currently valued at $370.18M.

If you're new to stock investing, here's how to buy Denali Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.